EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitDelphi-Studie

Pediatric Recurrent Croup: An International Delphi Consensus Statement

Thomas James Crotty, Eoin Francis Cleere iD, Feras Alhyari, Antonia McBride, Simone Schaefer, Colleen Bernadette Heffernan

The Laryngoscope · 30.10.2026

DOI: 10.1002/lary.71022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Laryngoscope, online erschienen am 30.10.2026. Verfasst von Thomas James Crotty und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Children's Health Ireland at Temple Street, Dublin, Ireland. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Recurrent croup lacks a consistent diagnostic definition, resulting in substantial variation in investigation and management. We aimed to develop international consensus‐based recommendations for the evaluation and management of pediatric recurrent croup. Data Sources PubMed/MEDLINE, Scopus, Cochrane Library, and EMBASE searched from 1st January 2000 to 15th August 2026, with results reported in accordance with PRISMA guidelines. Review Methods An international modified Delphi consensus process was conducted. Panelists rated statements using a 9‐point Likert scale across two rounds. Strong consensus was defined as a mean ≥ 8.00 with no outliers; consensus as mean ≥ 7.00 with no more than one outlier.

Results

Review of 28 studies confirmed substantial heterogeneity in the definition and investigation of recurrent croup, with most studies at moderate to high risk of bias. Strong consensus was achieved on prioritizing direct laryngoscopy and bronchoscopy in atypical presentations, including subglottic sizing and exclusion of a laryngeal cleft, and limiting allergy testing to children with clinical suspicion of atopic disease. Consensus supported shared otolaryngology–respiratory management, avoidance of routine imaging, and reserving advanced reflux investigation for refractory cases. No consensus was reached on empirical inhaled corticosteroids or antireflux therapy.

Conclusion

This study provides the first international multidisciplinary consensus guidance for the evaluation and management of recurrent croup, supported by a proposed risk‐stratified management algorithm. Agreement on core diagnostic and endoscopic priorities may help standardize clinical practice, while the absence of consensus on optimal medical management identifies clear priorities for future research in a field where high‐quality prospective data remain lacking. Level of Evidence N/A.

Schlagwörter

Stichwörter der Autor:innen

airwayotolaryngologypediatricsrecurrent croup

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Children's Health Ireland at Temple Street, Dublin, Ireland.
  • Department of Otolaryngology-Head and Neck Surgery, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Department of Paediatric Respiratory Medicine, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

ORCID-Profile: Eoin Francis Cleere

Zitieren

APA

Crotty, T. J., Cleere, E. F., Alhyari, F., McBride, A., Schaefer, S., & Heffernan, C. B. (2026). Pediatric Recurrent Croup: An International Delphi Consensus Statement. The Laryngoscope. https://doi.org/10.1002/lary.71022

Vancouver

Crotty TJ, Cleere EF, Alhyari F, McBride A, Schaefer S, Heffernan CB. Pediatric Recurrent Croup: An International Delphi Consensus Statement. The Laryngoscope. 2026. doi:10.1002/lary.71022

BibTeX
@article{Crotty2026,
  author = {Crotty, Thomas James and Cleere, Eoin Francis and Alhyari, Feras and McBride, Antonia and Schaefer, Simone and Heffernan, Colleen Bernadette},
  title = {Pediatric Recurrent Croup: An International Delphi Consensus Statement},
  journal = {The Laryngoscope},
  year = {2026},
  doi = {10.1002/lary.71022}
}
Kostenlos starten →